Pinnacle Conversation | Advancements in the Diagnosis and Treatment of Metabolism-Related Fatty Liver Disease: Discussing New Developments, Sharing Experiences from Singapore and the United States, and Addressing Global Progress
Non-alcoholic fatty liver disease (NAFLD)/metabolic-associated fatty liver disease (MAFLD) is on the rise globally and has become the leading cause of chronic liver disease in China, posing a significant threat to public health. Establishing diagnostic models based on risk factors to assist clinical diagnosis and classification, or developing non-invasive assessment methods, is an important prerequisite for identifying more patients and effectively intervening in the disease process.